Omphalos Lifesciences

Omphalos Lifesciences is a biotechnology company that develops Life Designer, an integrated biosystem design software platform. The company utilizes a hybrid approach combining biological rules and artificial intelligence to create programmable virtual cells and digital twins of biological systems. This technology allows researchers to model, simulate, and visualize complex biosystems, aiming to digitize and optimize biological processes similarly to how software is designed. By moving beyond traditional mathematical modeling, their platform provides a high-precision toolset for virtual biological experimentation and design.

This technology is applied across several domains, including drug discovery, precision medicine, biomanufacturing scale-up, and sustainable development. By enabling rapid, virtual testing on human and microbial models, the company helps partners reduce technical uncertainty and development costs while accelerating innovation. Omphalos has received support from the Biomedical Advanced Research and Development Authority (BARDA) through the Paratus digital health program to advance pathogen-agnostic antimicrobial strategies and has participated in the NVIDIA Inception program to scale its virtual cell infrastructure. Founded in 2021 and headquartered in Dallas, Texas, the company actively collaborates with research institutions to translate its computational modeling into real-world scientific solutions.